Nuveen’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.5M | Buy |
203,078
+85,702
| +73% | +$7.75M | 0.01% | 1185 |
|
|
2026
Q1 | $10.2M | Buy |
117,376
+1,442
| +1% | +$140K | ﹤0.01% | 1539 |
|
|
2025
Q4 | $12.4M | Sell |
115,934
-2,030
| -2% | -$215K | ﹤0.01% | 1428 |
|
|
2025
Q3 | $11.9M | Sell |
117,964
-3,891
| -3% | -$361K | ﹤0.01% | 1455 |
|
|
2025
Q2 | $7.7M | Sell |
121,855
-25,446
| -17% | -$1.56M | ﹤0.01% | 1662 |
|
|
2025
Q1 | $7.8M | Buy |
147,301
+398
| +0.3% | +$22.1K | ﹤0.01% | 1694 |
|
|
2024
Q4 | $8.22M | Sell |
146,903
-972
| -0.7% | -$53.7K | ﹤0.01% | 1694 |
|
|
2024
Q3 | $7.75M | Sell |
147,875
-1,244
| -0.8% | -$59.6K | ﹤0.01% | 1760 |
|
|
2024
Q2 | $6.12M | Buy |
149,119
+6,384
| +4% | +$255K | ﹤0.01% | 1844 |
|
|
2024
Q1 | $6.18M | Sell |
142,735
-934
| -0.7% | -$40.9K | ﹤0.01% | 1864 |
|
|
2023
Q4 | $6.6M | Buy |
143,669
+2,084
| +1% | +$65.7K | ﹤0.01% | 1817 |
|
|
2023
Q3 | $3.25M | Sell |
141,585
-56,858
| -29% | -$1.27M | ﹤0.01% | 2076 |
|
|
2023
Q2 | $3.27M | Buy |
198,443
+149,039
| +302% | +$2.69M | ﹤0.01% | 2120 |
|
|
2023
Q1 | $881K | Buy |
49,404
+1,913
| +4% | +$48K | ﹤0.01% | 2651 |
|
|
2022
Q4 | $1.38M | Buy |
47,491
+7,201
| +18% | +$185K | ﹤0.01% | 2541 |
|
|
2022
Q3 | $987K | Sell |
40,290
-915
| -2% | -$17K | ﹤0.01% | 2759 |
|
|
2022
Q2 | $171K | Sell |
41,205
-158,745
| -79% | -$869K | ﹤0.01% | 3162 |
|
|
2022
Q1 | $2.25M | Sell |
199,950
-2,428
| -1% | -$21.3K | ﹤0.01% | 2448 |
|
|
2021
Q4 | $2.02M | Sell |
202,378
-11,604
| -5% | -$130K | ﹤0.01% | 2560 |
|
|
2021
Q3 | $2.79M | Sell |
213,982
-36,274
| -14% | -$554K | ﹤0.01% | 2520 |
|
|
2021
Q2 | $4.9M | Buy |
250,256
+96,987
| +63% | +$2.01M | ﹤0.01% | 2259 |
|
|
2021
Q1 | $3.26M | Buy |
153,269
+18,163
| +13% | +$527K | ﹤0.01% | 2378 |
|
|
2020
Q4 | $4.02M | Buy |
135,106
+15,447
| +13% | +$393K | ﹤0.01% | 2182 |
|
|
2020
Q3 | $2.59M | Buy |
119,659
+1,882
| +2% | +$43.1K | ﹤0.01% | 2255 |
|
|
2020
Q2 | $2.63M | Buy |
117,777
+11,181
| +10% | +$218K | ﹤0.01% | 2224 |
|
|
2020
Q1 | $1.62M | Buy |
106,596
+6,855
| +7% | +$123K | ﹤0.01% | 2287 |
|
|
2019
Q4 | $2.29M | Buy |
99,741
+26,025
| +35% | +$578K | ﹤0.01% | 2373 |
|
|
2019
Q3 | $1.59M | Sell |
73,716
-3,469
| -4% | -$74.4K | ﹤0.01% | 2505 |
|
|
2019
Q2 | $1.7M | Buy |
+77,185
| New | +$1.95M | ﹤0.01% | 2510 |
|
Other funds holding RYTM
RCM
BBA
PA
Nuveen's RYTM Position: Q2 2026 in Review
Nuveen increased its Rhythm Pharmaceuticals (RYTM) stake by 73% in Q2 2026, buying an estimated $7.75M and bringing the position to 203,078 shares worth $22.5M. The position accounts for 0.01% of the portfolio, ranked #1185.
Nuveen first reported a position in RYTM in Q2 2019 and has held it in 29 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.
- Nuveen held 203,078 shares of Rhythm Pharmaceuticals worth $22.5M as of Q2 2026.
- Nuveen bought 85,702 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $7.75M.
- Rhythm Pharmaceuticals made up 0.01% of Nuveen's portfolio in Q2 2026, its #1185 holding.
- Nuveen first reported a position in Rhythm Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
- 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.